KRAS and cancer: Attempts of gene editing in KRAS have been reported in cancer studies using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated protein 9 (Cas9) technology to generate double-strand breaks and disrupt variant KRAS alleles (Lee et al, 2018; Kim et al, 2018).